BLUE
Profile banner
JA
JCS/T2D - A Diabetes Journey
@jcst2d.bsky.social
I draw on my professional expertise in data analysis and my personal health journey with Type 2 Diabetes to make technical information about T2D and obesity more accessible.
7 followers1 following34 posts
JAjcst2d.bsky.social

Eli Lilly has launched Zepbound single-dose vials at half the price of other incretin medicines, expanding access to obesity treatment. This provides an affordable option for those needing to self-pay. jcst2d.com/index.php?vi...#Healthcare#Obesity#EliLilly#Zepbound#AffordableCare

Image of a Zepbound (tirzepatide) 2.5 mg/0.5 mL single-dose vial for subcutaneous injection. Photo courtesy of Eli Lilly.
0

Profile banner
JA
JCS/T2D - A Diabetes Journey
@jcst2d.bsky.social
I draw on my professional expertise in data analysis and my personal health journey with Type 2 Diabetes to make technical information about T2D and obesity more accessible.
7 followers1 following34 posts